Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Duramesh repair versus minimally invasive IPOM for high-risk umbilical hernia

Official title: Duramesh Versus Minimally Invasive Intraperitoneal Onlay Mesh (IPOM) for High-Risk Umbilical Hernia Repairs: A Randomized Controlled Trial

Run by Northwestern University · NCT07881354 · Data updated 2026-11-12

This trial tests whether Duramesh repair can match the pain outcomes of minimally invasive IPOM in adults with high-risk umbilical or ventral hernias.

More Ventral Hernia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedOctober 23, 2026
Main results expectedOctober 2027
Study endsOctober 2029
Registry record updatedNovember 6, 2026
Trial IDNCT07881354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with symptomatic umbilical hernia (fascial defect ≥1 cm) and at least one high-risk comorbidity (BMI ≥30, active smoker, diabetes, or COPD) undergoing elective repair.

Probably not a fit

Patients without high-risk comorbidities or those with large hernias (>6 cm) or other exclusion criteria may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, randomized trial compares two surgical approaches for elective umbilical hernia repair in adults with obesity, diabetes, smoking, or COPD. Participants are randomized after consent to receive either Duramesh suture repair or minimally invasive IPOM, with standardized pre- and postoperative care. The primary outcome is postoperative day 1 pain, with non-inferiority defined as the upper bound of the 95% CI for the pain difference not exceeding 2 points on the NRS; if non-inferiority is shown, superiority is tested. Secondary outcomes include complications, quality of life, return to activity, costs, and hernia recurrence up to 2 years. Most secondary data come from the ACHQC registry, and follow-up includes recurrence or reoperation events as applicable.

Why it matters

Potential benefit: If successful, this approach could reduce pain and improve recovery for high-risk patients undergoing umbilical hernia repair.

How similar studies have gone: Prior work suggests mesh-based repairs reduce recurrence versus sutures, but this specific Duramesh vs IPOM approach in high-risk patients is being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Symptomatic umbilical hernia with fascial defect ≥1 cm
* At least one high-risk comorbidity: BMI ≥30, active smoking, diabetes, or COPD
* Undergoing elective repair

Exclusion Criteria:

* Hernia defect \>6 cm
* Urgent or emergent presentation
* CDC wound class II-IV
* Prior mesh at the umbilicus
* Ascites
* Pregnancy

Where it's running

  • Northwestern Memorial Hospital
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.